Michael Weiner, the executive director of the player's union, said he expects MLB to present its findings from the Biogenesis investigation "within the next month."
Given the potential length of an appeal process for the players involved, principal players in the Biogenesis investigation could be in limbo into the offseason.
Weiner also said the commissioner's office isn't bound by the terms of the joint drug prevention and treatment program because the players involved in the Biogenesis case did not fail tests and are being investigated for "non-analytical" reasons.